The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 18723550)

Published in Ann Oncol on August 22, 2008

Authors

J Polesel1, A Zucchetto, M Montella, L Dal Maso, A Crispo, C La Vecchia, D Serraino, S Franceschi, R Talamini

Author Affiliations

1: S.O.C. Epidemiologia e Biostatistica, IRCCS, Centro di Riferimento Oncologico, Aviano, Pordenone, Italy. polesel@cro.it

Articles citing this

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res (Phila) (2012) 1.90

Non-viral causes of hepatocellular carcinoma. World J Gastroenterol (2010) 1.63

What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol (2009) 1.24

Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research. PLoS One (2012) 1.13

Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics (2012) 1.10

Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer (2012) 1.09

Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging (2013) 1.00

Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China. BMC Public Health (2012) 1.00

FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. Cancer Epidemiol Biomarkers Prev (2011) 1.00

The role of leptin in the control of insulin-glucose axis. Front Neurosci (2013) 1.00

Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol (2014) 0.99

Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. J Gastroenterol (2011) 0.99

HCC, diet and metabolic factors: Diet and HCC. Hepat Mon (2011) 0.97

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. Oncologist (2012) 0.97

Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy. Int J Mol Sci (2015) 0.95

Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94

Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol (2013) 0.94

Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol (2013) 0.93

Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients. World J Gastroenterol (2011) 0.88

Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area. PLoS One (2013) 0.86

Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment. Open Access Maced J Med Sci (2015) 0.86

Excess body mass index and risk of liver cancer: a nonlinear dose-response meta-analysis of prospective studies. PLoS One (2012) 0.85

Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai. BMC Cancer (2015) 0.84

Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies. Oncologist (2012) 0.83

Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol (2013) 0.82

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study. BMC Cancer (2012) 0.80

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma. BMC Cancer (2015) 0.80

Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China. Onco Targets Ther (2014) 0.80

Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. Cancer (2016) 0.80

Steatosis and hepatitis C. Gastroenterol Rep (Oxf) (2015) 0.79

The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. World J Surg (2015) 0.79

Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese mice. Mol Ther (2014) 0.79

Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies. World J Gastroenterol (2013) 0.79

Leptin signaling molecular actions and drug target in hepatocellular carcinoma. Drug Des Devel Ther (2014) 0.79

Increasing incidence in liver cancer in Canada, 1972-2006: Age-period-cohort analysis. J Gastrointest Oncol (2011) 0.78

The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma. Gastroenterol Res Pract (2011) 0.78

Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma. World J Gastroenterol (2016) 0.76

Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study. Cancer Epidemiol (2016) 0.76

Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma. Exp Ther Med (2010) 0.75

Coffee consumption and risk of hepatocellular carcinoma: a meta-analysis of eleven epidemiological studies. Onco Targets Ther (2016) 0.75

Prevalence of and factors influencing impaired glucose tolerance among hepatitis B carriers: a nationwide cross-sectional study in the Republic of Korea. Medicine (Baltimore) (2014) 0.75

Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings. Eur Radiol (2014) 0.75

Articles by these authors

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet (2005) 7.09

The European mesothelioma epidemic. Br J Cancer (1999) 6.28

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer (2003) 4.40

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol (2001) 3.29

Intake of macronutrients and risk of breast cancer. Lancet (1996) 2.81

Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77

European cancer mortality predictions for the year 2013. Ann Oncol (2013) 2.71

The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol (1990) 2.62

Epidemiology of biliary tract cancers: an update. Ann Oncol (2008) 2.51

Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res (1990) 2.49

A meta-analysis of alcohol drinking and cancer risk. Br J Cancer (2001) 2.47

Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol (2012) 2.45

Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart (2002) 2.34

Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27

Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25

European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17

Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol (2014) 2.15

Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer (1991) 2.14

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908. Ann Oncol (2009) 2.13

A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08

Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07

Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04

Childhood cancer mortality in Italy. Lancet (1996) 2.02

Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol (2001) 1.95

Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95

Fish consumption and cancer risk. Am J Clin Nutr (1999) 1.94

The epidemiology of endometrial cancer. Gynecol Oncol (1991) 1.94

High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS (1996) 1.92

Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol (2008) 1.91

Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst (1998) 1.91

Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod (1994) 1.91

Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer (2007) 1.87

"Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet (1984) 1.87

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86

Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol (2011) 1.84

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83

Family history and the risk of stomach and colorectal cancer. Cancer (1992) 1.83

Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83

Western and eastern European trends in testicular cancer mortality. Lancet (2001) 1.80

Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol (2013) 1.79

Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis (2001) 1.77

Relative and attributable risk for cervical cancer: a comparative study in the United States and Italy. Int J Epidemiol (1990) 1.77

A case-control study of diabetes mellitus and cancer risk. Br J Cancer (1994) 1.76

Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75

Classic kaposi sarcoma: epidemiology and risk factors. Cancer (2000) 1.74

Lung cancer mortality in European women: recent trends and perspectives. Ann Oncol (2005) 1.73

Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer (1997) 1.71

A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control (2000) 1.70

Hormonal contraception and risk of cancer. Hum Reprod Update (2010) 1.69

Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer (1997) 1.68

The role of reproductive and menstrual factors in cancer of the breast before and after menopause. Eur J Cancer (1996) 1.67

Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur J Cancer (2009) 1.66

Body weight and the prevalence of chronic diseases. J Epidemiol Community Health (1988) 1.66

Genital warts and cervical neoplasia: an epidemiological study. Br J Cancer (1983) 1.65

An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med (1990) 1.65

Pancreatitis and the risk of pancreatic cancer. Pancreas (1995) 1.64

Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin. AIDS (2001) 1.64

Validation of a food-frequency questionnaire to assess dietary intakes in cancer studies in Italy. Results for specific nutrients. Ann Epidemiol (1996) 1.64

Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol (1982) 1.64

Short term increase in risk of breast cancer after full term pregnancy. BMJ (1988) 1.63

A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol (2011) 1.62

Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J (2009) 1.62

Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62

Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer (1986) 1.61

Olive oil, other dietary fats, and the risk of breast cancer (Italy). Cancer Causes Control (1995) 1.61

The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61

Cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Natl Cancer Inst (1998) 1.58

Prognostic factors of malignant mesothelioma of the pleura. Cancer (1993) 1.58